1. Home
  2. ASMB vs RYAM Comparison

ASMB vs RYAM Comparison

Compare ASMB & RYAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$35.44

Market Cap

512.1M

Sector

Health Care

ML Signal

HOLD

Logo Rayonier Advanced Materials Inc.

RYAM

Rayonier Advanced Materials Inc.

HOLD

Current Price

$8.56

Market Cap

580.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASMB
RYAM
Founded
2005
1926
Country
United States
United States
Employees
N/A
2325
Industry
Biotechnology: Pharmaceutical Preparations
Paper
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
512.1M
580.4M
IPO Year
2010
2014

Fundamental Metrics

Financial Performance
Metric
ASMB
RYAM
Price
$35.44
$8.56
Analyst Decision
Strong Buy
Buy
Analyst Count
5
1
Target Price
$44.20
$14.00
AVG Volume (30 Days)
289.7K
701.1K
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
91.78
N/A
EPS
N/A
N/A
Revenue
N/A
$1,466,397,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$638.39
$8.22
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.23
$5.38
52 Week High
$39.71
$11.85

Technical Indicators

Market Signals
Indicator
ASMB
RYAM
Relative Strength Index (RSI) 62.24 47.65
Support Level $32.57 $8.18
Resistance Level $37.00 $8.82
Average True Range (ATR) 1.56 0.30
MACD 0.02 -0.02
Stochastic Oscillator 65.20 23.50

Price Performance

Historical Comparison
ASMB
RYAM

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

About RYAM Rayonier Advanced Materials Inc.

Rayonier Advanced Materials Inc engaged in the production and sale of high-purity cellulose and other cellulose-based materials derived from renewable wood fiber. The company operates through five segments: Cellulose Specialties, which produces purified cellulose used in products such as filters, pharmaceuticals, food additives and electronics; Biomaterials, which produces products including biofuels, lignosulfonates and other bio-based chemicals; Cellulose Commodities, which manufactures absorbent and viscose pulp used in textiles and hygiene products; Paperboard, which produces coated paperboard used for packaging and printing applications; and High-Yield Pulp, which produces pulp used in paperboard, packaging and printing paper products.

Share on Social Networks: